Evidence map›Paper›PMID 36558337›Full record

ArticleNanomaterials (Basel, Switzerland)2022

CeO

Sofia Khabirova, Gleb Aleshin, Tatiana Plakhova, Anastasia Zubenko, Anna Shchukina, Olga Fedorova, Aleksey Averin, Ekaterina Belova, Elena Bazarkina, Kristina Kvashnina and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Sofia KhabirovaDepartment of Chemistry, Lomonosov Moscow State University, Leninskie Gory, 1/3, 119991 Moscow, Russia.ORCID 0000-0002-8383-3272
Gleb AleshinDepartment of Chemistry, Lomonosov Moscow State University, Leninskie Gory, 1/3, 119991 Moscow, Russia.ORCID 0000-0002-9725-2217
Tatiana PlakhovaDepartment of Chemistry, Lomonosov Moscow State University, Leninskie Gory, 1/3, 119991 Moscow, Russia.
Anastasia ZubenkoN. Nesmeyanov Institute of Organoelement Compounds of Russian Academy of Sciences, Vavilova, 28, GSP-1, 119991 Moscow, Russia.
Anna ShchukinaN. Nesmeyanov Institute of Organoelement Compounds of Russian Academy of Sciences, Vavilova, 28, GSP-1, 119991 Moscow, Russia.ORCID 0000-0003-0660-086X
Olga FedorovaN. Nesmeyanov Institute of Organoelement Compounds of Russian Academy of Sciences, Vavilova, 28, GSP-1, 119991 Moscow, Russia.
Aleksey AverinFrumkin Institute of Physical Chemistry and Electrochemistry Russian Academy of Sciences, Leninskiy Ave. 31b4, 119991 Moscow, Russia.
Ekaterina BelovaDepartment of Chemistry, Lomonosov Moscow State University, Leninskie Gory, 1/3, 119991 Moscow, Russia.
Elena BazarkinaThe Rossendorf Beamline at ESRF-The European Synchrotron, CS40220, CEDEX 9, 38043 Grenoble, France.
Kristina KvashninaThe Rossendorf Beamline at ESRF-The European Synchrotron, CS40220, CEDEX 9, 38043 Grenoble, France.
Stepan KalmykovDepartment of Chemistry, Lomonosov Moscow State University, Leninskie Gory, 1/3, 119991 Moscow, Russia.

Funding

European Research Council 759696Russian Ministry of Science and Education 075-15-2021-1353Russian Science Foundation 21-73-00101
6 · The paper itself

Abstract

This study is one of the first attempts to assess CeO

Indexed as

bismuthnanoceriaradiolabeled nanoparticlesradiopharmaceuticalssurface functionalization

Identifiers

PMID36558337
PMCPMC9783244

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.